Personalized heart ablation may beat standard treatment for AFib
NCT ID NCT04823299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new, tailored ablation approach to the standard treatment for people with paroxysmal atrial fibrillation (AFib), a common heart rhythm problem. About 556 adults with AFib will be randomly assigned to either standard pulmonary vein isolation or a procedure that targets their specific triggers. The goal is to see which method better prevents AFib from coming back and improves safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McGill University Health Center
NOT_YET_RECRUITINGMontreal, Quebec, H3G 1A4, Canada
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, K1Y 4W7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Can a chest scan shortcut dangerous heart rhythm surgery?
- Could a bigger balloon tame the Heart's electrical chaos?
- Could a new injection tame atrial fibrillation?
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test